Maria Graciela Miranda

Title: Maria Graciela Miranda: Innovator in Serotonin Reuptake Inhibitors

Introduction

Maria Graciela Miranda is a notable inventor based in Waco, Texas. She has made significant contributions to the field of pharmacology, particularly in the development of serotonin reuptake inhibitors. Her work focuses on creating effective treatments for depression with fewer side effects.

Latest Patents

Maria holds a patent for a serotonin reuptake inhibitor that can be utilized in the treatment of depression. This innovative compound is designed to minimize unwanted side effects commonly associated with traditional SSRIs. The invention combines serotonin transporter reuptake inhibition with serotonin receptor antagonism, making it a bi-functional organic molecule. The serotonin-selective reuptake inhibitor portion of the molecule exhibits an affinity for the serotonin reuptake transporter, contributing to its antidepressant properties. Additionally, the piperazine or piperidine portion of the molecule targets 5-HT receptors, effectively addressing the undesired side effects of SSRIs. Maria has 1 patent to her name.

Career Highlights

Maria Graciela Miranda is affiliated with Baylor University, where she conducts her research and development work. Her academic background and professional experience have positioned her as a key figure in her field.

Collaborations

Maria has collaborated with esteemed colleagues, including Kevin G Pinney and James Michael Dorsey. These partnerships have enhanced her research efforts and contributed to the advancement of her innovative projects.

Conclusion

Maria Graciela Miranda is a pioneering inventor whose work in serotonin reuptake inhibitors is making a significant impact in the treatment of depression. Her dedication to reducing side effects in pharmacological treatments showcases her commitment to improving patient care.